Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Chackalamannil

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 29, 2005
Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonistsMartin C Clasby, Samuel Chackalamannil, Michael Czarniecki, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunctionDmitri A Pissarnitski, Theodros Asberom, Craig D Boyle, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2009
Diaryl piperidines as CB1 receptor antagonistsJack D Scott, Sarah W Li, Hongwu Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2007
Himbacine derived thrombin receptor antagonists: discovery of a new tricyclic coreMartin C Clasby, Samuel Chackalamannil, Michael Czarniecki, et al.
Journal of Medicinal Chemistry|December 3, 2002
Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonistsYuguang Wang, Samuel Chackalamannil, Zhiyong Hu, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Discovery of hydroxy pyrimidine Factor IXa inhibitorsCharles L Jayne, Teresa Andreani, Tin-Yau Chan, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitorsYuguang Wang, Samuel Chackalamannil, Zhiyong Hu, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Enhancement of pharmacokinetic properties and in vivo efficacy of benzylidene ketal M(2) muscarinic receptor antagonists via benzamide modificationCraig D Boyle, Susan F Vice, Jennifer Campion, et al.
Journal of Medicinal Chemistry|January 5, 2007
Metabolism-based identification of a potent thrombin receptor antagonistMartin C Clasby, Samuel Chackalamannil, Michael Czarniecki, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male EDCraig D Boyle, Ruo Xu, Theodros Asberom, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|December 29, 2005
Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonistsMartin C Clasby, Samuel Chackalamannil, Michael Czarniecki, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunctionDmitri A Pissarnitski, Theodros Asberom, Craig D Boyle, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2009
Diaryl piperidines as CB1 receptor antagonistsJack D Scott, Sarah W Li, Hongwu Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2007
Himbacine derived thrombin receptor antagonists: discovery of a new tricyclic coreMartin C Clasby, Samuel Chackalamannil, Michael Czarniecki, et al.
Journal of Medicinal Chemistry|December 3, 2002
Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonistsYuguang Wang, Samuel Chackalamannil, Zhiyong Hu, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Discovery of hydroxy pyrimidine Factor IXa inhibitorsCharles L Jayne, Teresa Andreani, Tin-Yau Chan, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitorsYuguang Wang, Samuel Chackalamannil, Zhiyong Hu, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Enhancement of pharmacokinetic properties and in vivo efficacy of benzylidene ketal M(2) muscarinic receptor antagonists via benzamide modificationCraig D Boyle, Susan F Vice, Jennifer Campion, et al.
Journal of Medicinal Chemistry|January 5, 2007
Metabolism-based identification of a potent thrombin receptor antagonistMartin C Clasby, Samuel Chackalamannil, Michael Czarniecki, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male EDCraig D Boyle, Ruo Xu, Theodros Asberom, et al.
Pageof 5